Pyroptosis
Pyroptosis is a form of regulated cell death characterized by inflammatory signaling, disruption of the plasma membrane, and release of intracellular danger signals.
Pyroptosis is a form of regulated cell death characterized by inflammatory signaling, disruption of the plasma membrane, and release of intracellular danger signals. It is commonly initiated by inflammasomes such as the NLRP3 inflammasome, which activate caspase-1. Caspase-1 cleaves Gasdermin D (GSDMD), releasing its pore-forming fragment and promoting cellular swelling, membrane rupture, and secretion of interleukin-1β (IL-1β) and interleukin-18 (IL-18). Pyroptosis can also be initiated through non-canonical inflammasome pathways, which respond to cytosolic lipopolysaccharide and activate inflammatory caspases that converge on GSDMD.
Additional pyroptotic routes involve apoptotic caspases and other gasdermins. For example, caspase-3 can cleave Gasdermin E (GSDME), thereby redirecting apoptotic signaling toward a pyroptosis-like, inflammatory form of cell death. Release of high mobility group box 1 (HMGB1), proinflammatory cytokines, and other damage-associated molecular patterns can amplify inflammation and influence macrophage activity, antigen presentation, and adaptive immune responses. In contrast with the generally immunologically quiet dismantling associated with apoptosis, pyroptosis is considered an immunogenic cell-death modality that can stimulate dendritic-cell and T-cell responses; it is therefore studied both as a driver of inflammatory disease and as a potential mechanism for cancer therapy.
Where the papers sit
12 papers from the last 6 months study pyroptosis directly · updated from PubMed 16 Nov 2026
Study type 0 clinical trials · 1 human data · 11 preclinical
Themes 3 themes · 1 paradigm shift
-
Inflammatory Tissue Injury
Inhibiting NLRP3- and GSDMD-linked inflammation is being tested across metabolic, vascular, endocrine and skeletal tissue injury. Candidate interventions act through Piezo1-associated cGAS-STING signalling, the TNF-α/HMGB1/TLR4/MyD88/NF-κB pathway, HIF-1α inhibition or TMAO-driven NLRP3 activation. The recurring endpoints are reduced pyroptosis, inflammation and fibrosis, with cardiac aging and diabetic organ damage prominent. Evidence remains preclinical and mechanism-focused, without a single dominant therapeutic strategy.
5 papers · 41.7%
-
Pyroptosis-Driven Cancer Immunity
Inducing GSDME-mediated pyroptosis is being combined with immune reprogramming, radiotherapy and other immunogenic death pathways. Biomimetic exosomes, nanovesicles, copper single-atom nanozymes and mitochondria-targeted photosensitizers aim to release tumor antigens and damage-associated molecular patterns. Disulfidptosis combinations and photosensitizer-based approaches extend the strategy beyond pyroptosis alone. The open question is whether these platforms can convert stronger local tumor killing into durable T-lymphocyte control across glioblastoma, breast cancer and multiple myeloma.
5 papers · 41.7%
-
Inflammasome-Driven Tissue Injury
Suppressing inflammasome-mediated pyroptosis is being pursued to protect injured tissues. In gestational diabetes, METTL14 acts through m6A modification of the lncRNA MEG8/WNT7A axis in placental trophoblasts. Aconitine similarly limits inflammasome activation during peripheral nerve injury and supports recovery. The shared direction is mechanistic control of inflammatory cell death rather than direct tissue replacement.
2 papers · 16.7%
Pyroptosis can be therapeutically routed through apoptotic caspases and GSDME rather than being confined to inflammasome–caspase-1–GSDMD signaling
Mito-Ir photodynamic therapy in breast cancer and QSSC@Exo-LNP nanotherapy in glioblastoma independently found that mitochondrial or death-receptor-linked apoptotic caspases can activate GSDME-mediated pyroptosis: light-activated Mito-Ir used the caspase-3/GSDME pathway, while chlorogenic acid in QSSC@Exo-LNP initiated GSDME pyroptosis through caspase-8 and amplified it through caspase-3 42489638Jul 42466899Jul. Much of the set instead treats pyroptosis through inflammasome-associated caspase-1 and GSDMD, particularly in inflammatory and tissue-injury models. The change is that pyroptosis is not restricted to the canonical inflammatory machinery; apoptotic signaling can be deliberately rerouted into an immunogenic, GSDME-dependent death program, expanding therapeutic design beyond direct inflammasome activation 42489638Jul 42466899Jul.
Papers
The 12 papers from the last 6 months that study pyroptosis directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Inflammatory Tissue Injury (5)
- M-SYFSF attenuates diabetic kidney disease by suppressing Piezo1-associated cGAS-STING signalling and tubular pyroptosis. Phytomedicine : international journal of phytotherapy and phytopharmacology · 2 Sept 2026 PMID 42685564
- Acellular matrix microgel assembly integrated with curcumin-loaded ZIF-8 nanoparticles and simvastatin promotes microfracture-based articular cartilage repair via pyroptosis inhibition, endogenous BMSC recruitment, and hyaline chondrogenic differentiation. Journal of materials chemistry. B · 11 Aug 2026 PMID 42576623
- Digoxin inhibits HIF-1α to attenuate inflammation and fibrosis in thyroid eye disease. Biochemical and biophysical research communications · 24 Jul 2026 PMID 42497831
- Trimethylamine N-oxide drives cardiac aging by activating NLRP3-mediated pyroptosis. Life sciences · 9 Jun 2026 PMID 42264141
- Tumour Necrosis Factor-α Promotes Pyroptosis in Diabetic Liver Injury via the HMGB1/TLR4/MyD88/NF-κB Pathway. Journal of cellular and molecular medicine · 31 May 2026 PMID 42219549
Pyroptosis-Driven Cancer Immunity (5)
- Activating a novel cell death pathway to target PI-resistant multiple myeloma and enhance immunogenic cell death. Apoptosis : an international journal on programmed cell death · 7 Sept 2026 PMID 42704369
- Biomimetic nanovesicle mediated GSDME delivery reprograms the tumor immune microenvironment via pyroptosis to enhance radiotherapy. Journal of controlled release : official journal of the Controlled Release Society · 23 Jul 2026 PMID 42492635
- A Mitochondria-Targeted Iridium(III) Complex as a Potent Type-I/II Photosensitizer for Pyroptosis-Based Breast Cancer Therapy. Journal of medicinal chemistry · 23 Jul 2026 PMID 42489638
- A Screening-Guided Biomimetic Exosome-Liposome Hybrid Nanoplatform Enables Pyroptosis-Enhanced Immune Reprogramming in Glioblastoma. ACS nano · 17 Jul 2026 PMID 42466899
- Axial Coordination and Defect Engineering of Copper-Based Single-Atom Nanozymes: Driving Synergistic Disulfidptosis and Pyroptosis for Efficient Prostate Cancer Immunotherapy. Angewandte Chemie (International ed. in English) · 9 Jul 2026 PMID 42424164
Inflammasome-Driven Tissue Injury (2)
- METTL14 alleviates pyroptosis of placental trophoblasts in gestational diabetes mellitus through the lncRNA MEG8/WNT7A axis via m6A modification. Functional & integrative genomics · 11 Sept 2026 PMID 42726311
- Aconitine promotes injured peripheral nerve recovery through restraining the activation of inflammasome-mediated cell pyroptosis and pathological inflammation. Experimental cell research · 21 Jul 2026 PMID 42480279
By study type
Human data, design not indexed (1)
- Axial Coordination and Defect Engineering of Copper-Based Single-Atom Nanozymes: Driving Synergistic Disulfidptosis and Pyroptosis for Efficient Prostate Cancer Immunotherapy. Angewandte Chemie (International ed. in English) · 9 Jul 2026 PMID 42424164
Preclinical: animal, cell and lab studies (11)
- METTL14 alleviates pyroptosis of placental trophoblasts in gestational diabetes mellitus through the lncRNA MEG8/WNT7A axis via m6A modification. Functional & integrative genomics · 11 Sept 2026 PMID 42726311
- Activating a novel cell death pathway to target PI-resistant multiple myeloma and enhance immunogenic cell death. Apoptosis : an international journal on programmed cell death · 7 Sept 2026 PMID 42704369
- M-SYFSF attenuates diabetic kidney disease by suppressing Piezo1-associated cGAS-STING signalling and tubular pyroptosis. Phytomedicine : international journal of phytotherapy and phytopharmacology · 2 Sept 2026 PMID 42685564
- Acellular matrix microgel assembly integrated with curcumin-loaded ZIF-8 nanoparticles and simvastatin promotes microfracture-based articular cartilage repair via pyroptosis inhibition, endogenous BMSC recruitment, and hyaline chondrogenic differentiation. Journal of materials chemistry. B · 11 Aug 2026 PMID 42576623
- Digoxin inhibits HIF-1α to attenuate inflammation and fibrosis in thyroid eye disease. Biochemical and biophysical research communications · 24 Jul 2026 PMID 42497831
- Biomimetic nanovesicle mediated GSDME delivery reprograms the tumor immune microenvironment via pyroptosis to enhance radiotherapy. Journal of controlled release : official journal of the Controlled Release Society · 23 Jul 2026 PMID 42492635
- A Mitochondria-Targeted Iridium(III) Complex as a Potent Type-I/II Photosensitizer for Pyroptosis-Based Breast Cancer Therapy. Journal of medicinal chemistry · 23 Jul 2026 PMID 42489638
- Aconitine promotes injured peripheral nerve recovery through restraining the activation of inflammasome-mediated cell pyroptosis and pathological inflammation. Experimental cell research · 21 Jul 2026 PMID 42480279
- A Screening-Guided Biomimetic Exosome-Liposome Hybrid Nanoplatform Enables Pyroptosis-Enhanced Immune Reprogramming in Glioblastoma. ACS nano · 17 Jul 2026 PMID 42466899
- Trimethylamine N-oxide drives cardiac aging by activating NLRP3-mediated pyroptosis. Life sciences · 9 Jun 2026 PMID 42264141
- Tumour Necrosis Factor-α Promotes Pyroptosis in Diabetic Liver Injury via the HMGB1/TLR4/MyD88/NF-κB Pathway. Journal of cellular and molecular medicine · 31 May 2026 PMID 42219549
Written from 12 PubMed abstracts, each one listed by PMID above. Published: 2026-08-28. Last written: 2026-09-13 by GPT. Drafted by language models from published abstracts; not medical advice.